8-K
filed November 19, 2024, 6:59 PM ET
ticker CDT
CIK 0001896212
leadership
confidence high
sentiment neutral
materiality 0.45
Conduit Pharma appoints director Fry (420K options); amends CFO pay (£400K, 40% bonus) and quorum rule
CDT Equity Inc.
- Simon Fry appointed as director effective Dec 18, 2024; receives initial option for 420,000 common shares.
- CFO James Bligh's employment amendment: £400K base salary, discretionary bonus up to 40%, 6-month notice.
- Bylaws amended: quorum reduced from majority to one-third voting power, effective after 2024 annual meeting.
Machine-readable event card
- schema_version
- secwatch.filing_event.v1
- accession
- 0001493152-24-046849
- form_type
- 8-K
- ticker
- CDT
- cik
- 0001896212
- company_name
- CDT Equity Inc.
- filed_at
- 2024-11-19T23:59:59+00:00
- discovered_at
- 2026-05-14T18:03:10.292024+00:00
- generated_at
- 2026-05-29T22:41:31.066582+00:00
- sec_items
- ["5.02", "5.03", "9.01"]
- event_type
- leadership
- sentiment
- neutral
- materiality_score
- 0.45
- calibrated_materiality_score
- 0.45
- confidence
- high
- secwatch_canonical_url
- https://secwatch.observer/filing/0001493152-24-046849
- json_url
- https://secwatch.observer/filing/0001493152-24-046849.json
- markdown_url
- https://secwatch.observer/filing/0001493152-24-046849.md
- text_url
- https://secwatch.observer/filing/0001493152-24-046849.txt
- edgar_index_url
- https://www.sec.gov/Archives/edgar/data/1896212/000149315224046849/0001493152-24-046849-index.htm
- edgar_primary_document_url
- https://www.sec.gov/Archives/edgar/data/1896212/000149315224046849/form8-k.htm
- generated_by_model
- deepseek-v4-flash:cloud@v2
- review_status
- machine_generated
- human_reviewed
- false
- corrected
- false
- correction_note
- null
- correction_timestamp
- null
- superseded_by
- null
Comparable filings
FIBK
First Interstate BancSystem: three directors retire per age policy; charter amended to plurality voting
FIRST INTERSTATE BANCSYSTEM INC
May 29, 2026, 4:26 PM ET
leadership
Items 5.02, 5.03, 5.07, 9.01
same fact type: executive_change
same SEC item: 5.02, 5.03, 9.01
same event type: leadership
similar materiality
This filing
the Board of Directors (the “Board”) of Conduit Pharmaceuticals Inc. (the “Company”) appointed Simon Fry as a director, and a member of the Audit Committee and the Compensation Committee, to become effective on December 18, 2024
Comparable filing
on May 27, 2026, each of Ms. Patricia L. Moss and Messrs. David L. Jahnke and Stephen M. Lacy, each having reached the retirement age of 72, was deemed to have retired and resigned automatically from the Company’s Board of Directors
Filing page
SEC filing
TKNO
Alpha Teknova director Irene Davis to retire; board reduced from 8 to 7; shareholder votes approved nominees and auditor
Alpha Teknova, Inc.
June 1, 2026, 5:22 PM ET
leadership
Items 5.02, 5.07, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
the Board of Directors (the “Board”) of Conduit Pharmaceuticals Inc. (the “Company”) appointed Simon Fry as a director, and a member of the Audit Committee and the Compensation Committee, to become effective on December 18, 2024
Comparable filing
On May 27, 2026, Irene Davis, a member of the Board of Directors (the “Board”) of Alpha Teknova, Inc. (the “Company”) and a member of the Nominating and Corporate Governance Committee, notified the Company of her intention not to stand for re-election to the Board at the Company’s 2026 Annual Meeting of Stockholders (the “Meeting”) and to retire from the Board and all committees thereof, effective upon the date of the Meeting.
Filing page
SEC filing
WTTR
Select Water Solutions COO Skarke moves to Chief Commercial Officer; no successor named
Select Water Solutions, Inc.
June 1, 2026, 5:00 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
the Board of Directors (the “Board”) of Conduit Pharmaceuticals Inc. (the “Company”) appointed Simon Fry as a director, and a member of the Audit Committee and the Compensation Committee, to become effective on December 18, 2024
Comparable filing
Effective June 1, 2026, Michael C. Skarke transitioned from serving as the Executive Vice President and Chief Operating Officer of Select Water Solutions, Inc. (the “Company”) to serving as the Company’s Executive Vice President and Chief Commercial Officer,
Filing page
SEC filing
JOB
Darla Moore resigns from GEE Group board effective June 1, 2026, due to other commitments
GEE Group Inc.
June 1, 2026, 4:47 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
the Board of Directors (the “Board”) of Conduit Pharmaceuticals Inc. (the “Company”) appointed Simon Fry as a director, and a member of the Audit Committee and the Compensation Committee, to become effective on December 18, 2024
Comparable filing
On June 1, 2026, GEE Group Inc. (the “Company”) (NYSE American: JOB) issued a press release announcing that Ms. Darla Moore, has resigned as a member of the Board of Directors (the “Board”) and from all committees of the Company’s Board effective June 1, 2026, due to the time requirements necessary for her existing and new business commitments.
Filing page
SEC filing
LPX
LP Building Solutions announces CFO succession: Alan Haughie to retire; Aaron Howald named CFO effective Sept 1, 2026
LOUISIANA-PACIFIC CORP
June 1, 2026, 4:31 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
the Board of Directors (the “Board”) of Conduit Pharmaceuticals Inc. (the “Company”) appointed Simon Fry as a director, and a member of the Audit Committee and the Compensation Committee, to become effective on December 18, 2024
Comparable filing
On May 27, 2026, Alan J.M. Haughie, Executive Vice President and Chief Financial Officer of Louisiana-Pacific Corporation (“LP”, the “Company”), notified the Board of Directors of LP (the “Board”) of his intention to retire from the role of Executive Vice President and Chief Financial Officer, effective September 1, 2026.
Filing page
SEC filing
LOGC
ContextLogic appoints Scott Stewart as CFO & COO effective June 1; interim CFO resigns
ContextLogic Holdings Inc.
June 1, 2026, 4:15 PM ET
leadership
Items 5.02, 7.01, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
the Board of Directors (the “Board”) of Conduit Pharmaceuticals Inc. (the “Company”) appointed Simon Fry as a director, and a member of the Audit Committee and the Compensation Committee, to become effective on December 18, 2024
Comparable filing
On June 1, 2026 the Company also announced the appointment of Scott Stewart, age 53, as Chief Financial Officer and Chief Operating Officer, effective June 1, 2026 (the “Effective Date”).
Filing page
SEC filing
VMI
Former CFO Thomas Liguori enters separation agreement; $4.9M retirement benefits
VALMONT INDUSTRIES INC
June 1, 2026, 4:15 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
the Board of Directors (the “Board”) of Conduit Pharmaceuticals Inc. (the “Company”) appointed Simon Fry as a director, and a member of the Audit Committee and the Compensation Committee, to become effective on December 18, 2024
Comparable filing
Valmont Industries Inc. previously reported the appointment of John Schwietz as Valmont’s Executive Vice President and Chief Financial Officer and Corporate Secretary, effective April 8, 2026, to succeed Thomas Liguori.
Filing page
SEC filing
PSQH
PSQ Holdings SVP of People Michael Hebert resigns; severance of $137,500
PSQ Holdings, Inc.
June 1, 2026, 4:02 PM ET
leadership
Items 5.02, 9.01
same fact type: executive_change
same SEC item: 5.02, 9.01
same event type: leadership
similar materiality
This filing
the Board of Directors (the “Board”) of Conduit Pharmaceuticals Inc. (the “Company”) appointed Simon Fry as a director, and a member of the Audit Committee and the Compensation Committee, to become effective on December 18, 2024
Comparable filing
On May 26, 2026, Michael Hebert resigned from his position of Senior Vice President of People of PSQ Holdings, Inc. (the “Company”), effective May 31, 2026.
Filing page
SEC filing
This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice.
See methodology for how this pipeline works.